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 Abstract 
Two novel members of the temporin family, named temporin-1Ee 
(FLPVIAGVLSKLFamide) and temporin-1Re (FLPGLLAGLLamide), whose biosynthetic 
precursor structures were deduced from clones obtained from skin secretion-derived cDNA 
libraries of the European edible frog, Pelophylax kl. esculentus, were obtained by ‘shotgun’ 
cloning. Deduction of the molecular masses of each mature processed peptide from 
respective cloned cDNAs was used to locate respective molecules in reverse-phase HPLC 
fractions of secretion. Temporin-1Ee(MIC=10µM) and temporin-1Re (MIC=60µM) were 
both found to be active against Gram-positive Staphylococcus aureus, but retaining a weak 
haemolytic activity.Single-site substitutions can dramatically change the spectrum of activity 
of a given temporin. Compared with temporine-1Ec, just one chemically-conservative 
substitution (Val8 instead of Leu8), temporin-1Ee bearing a net charge of +2 displaysbroad-
spectrum activity with particularly high potency on the clinically relevant Gram-negative 
strains, Escherichia coli (MIC=40µM). These factors bode well for translatingtemporinsto 
bepotential anti-infective drug candidates. 
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Introduction 
Temporins, containing 10-13 amino acid residues, are considered to be among the 
smallest AMPs found in Nature. They were initially described as the Vespa-like peptides, due 
to their sequence similarities with chemotactic and histamine-releasing peptides isolated from 
the venom of wasps of the genus Vespa, and were first identified in the skins of the European 
edible frog, Pelophylax kl. esculentus and the Asian frog, Rana erythraea. Afterwards, a 
family of 10, structurally-related peptides with antibacterial and antifungal properties were 
isolated from the electrically-stimulated skin secretions of the European common red frog, 
Rana temporaria, and called temporins A to L, in reflection of their source (1). Compared 
with other ranid frog skin AMPs that have a C-terminal heptapeptide ring constructed by a 
disulphide bridge, the temporins are C-terminally α-amidated and stabilised by helix-forming 
residues such as leucine, alanine and lysine. Due to their basic residues, temporins usually 
carry a net charge ranging from 0 to +4 at neutral pH and have a potent activity against 
Gram-positive bacteria including methicillin-resistant S. aureus (MRSA) with little toxicity 
to mammalian cells (2,3). However, since temporin L is the firstmember of this family 
isolated which exhibit broad spectra of activity against both Gram-positive and Gram-
negative bacteria（Giacometti et al 2006), a few new members of the temporin family, such 
as temporin-Sha, temporin-T1 and temporin-1DRa, have been found to display similar 
antimicrobial activitiesto temporine L(4, 5).  
Naturally occurring AMPs differ dramatically in various interrelated peptide parameters, 
including size, net charge, hydrophobicity, amphipathicity, degree of structure formation and 
flexibility（6-8） , thus the selectivity and mechanism of antimicrobial activitiesremain 
unknown.It is well accepted that differences in lipid composition of membranes among 
microorganisms play key roles in the selectivity of AMPs toward microbial cells (2), and 
 although the mechanism of action of temporinshave been only scarcely evaluated, most are 
supposed to have a classical membrane perturbing activity through a barrel-stave mechanism 
of action. In contrast, temporin L is presumed to insert into bacterial cell membranes through 
the formation of pore-like openings and interact with essential anionic targets inside the cells 
(1-3, 9-10). Temporins as short chain peptides of simple structure are considered to be good 
templates for new drug design. 
Herein, two novel antimicrobial peptides have been identified in the skin secretion of the 
European Edible frog, Pelophylax kl. esculentus, through initial molecular cloning of skin 
secretion-derived cDNAs. Deduced peptides were subsequently identified in fractions of skin 
secretion, chemically-synthesised and subjected to functional analyses. Sequence 
characterisation of the mature peptides demonstrated that they belonged to the temporin 
family found predominantly in the skin secretions of ranid frogs. Thus, these two peptides 
were named temporin-1Ee and temporin-1Re. Temporin-1Ee, which is an analogue of 
temporin-1Ec, has broad-spectrum antimicrobial activity at low micromolar concentrations. 
Temporin-1Re, with a net charge of +1, is weakly active against the Gram-positive 
bacterium, S. aureus, but is devoid of activity against Gram-negative bacteria and yeast.  
 
 
 
 
 
 
 
 
 
  
Materials and methods 
Preparation of P. kl.esculentusskin secretion 
P.kl.esculentus (n = 30) were obtained from a commercial source (Le QuerruyCellier, 
Notre Dame de Monts, France) and had been captive bred. The frogs were adults on receipt 
and were settled into their new surroundings for 3 months prior to secretion harvesting. They 
were maintained in our purpose-designed amphibian facility at 15–20 °C under a 12 h/12 h 
light/dark cycle and fed multivitamin-loaded crickets three times per week. Skin secretion 
was obtained from dorsal skin by mild transdermal electrical stimulation (5V; 3 ms pulses) 
for 30 s. The skin secretion was washed from the skin using deionized water, snap-frozen in 
liquid nitrogen, and lyophilized. Lyophilizate was stored at −20 °C prior to analysis. 
“Shotgun” cloning of Pelophylax kl. esculentus skin secretion-derived cDNA 
Five milligrams of lyophilised skin secretion were dissolved in 1ml lysis/binding buffer 
(Dynal, UK) to stabilise mRNA. Polyadenylated mRNA was trapped and isolated by means 
of magnetic oligo-dTDynabeads as described by the manufacturer (Dynal, UK). The trapped 
template polyadenylated mRNA was employed to manufacture a cDNA library using reverse 
transcriptase and a sample of this library was subjected to 5′- and 3′-rapid amplification of 
cDNA ends (RACE) procedures to obtain full-length antimicrobial peptide precursor nucleic 
acid sequence data using a SMART-RACE kit (Clontech UK) following manufacturer's 
instructions. Briefly, the 5′-RACE reactions employed the forward primer (5′-
ATGTTCACCATGAAGAAATC-3′) and the reverse primer (5′-CTATCCCACATC 
AGGAGACTTTCC-3′) were designed according to the nucleotide sequence of temporin 
precursor cDNAs obtained from other ranid frogs. The 5′-RACE reactions were purified and 
cloned using a pGEM-T vector system (Promega Corporation) and sequenced using an ABI 
3730 automated sequencer (Applied Biosystems, Foster City, CA, USA).   
 Reverse phase HPLC fractionation of skin secretion 
A further 1mg sample of lyophilised skin secretion was dissolved in 0.5ml of 0.05/99.5 
(v/v) trifluoroacetic acid (TFA)/water and clarified of microparticulates by centrifugation. 
The supernatant was then subjected to HPLC using a gradient formed from 0.05/99.5 (v/v) 
TFA/water to 0.05/29.95/70.0 (v/v/v) TFA/water/acetonitrile in 240min at a flow rate of 1 
ml/min. A Cecil Adept Binary HPLC system (Adept Technology, Inc. USA), fitted with an 
analytical column (a Jupiter 00G4052 semi-preparative C-5 column 25x1cm, Phenomenex, 
U.K.) was employed and this was interfaced with a Thermo Fisher Scientific LCQ Fleet 
electrospray ion-trap mass spectrometer. The effluent from the chromatographic column was 
flow-split with approximately 10% entering the mass spectrometer source and 90% directed 
towards a fraction collector. Dead volume between column and fraction collector was 
minimal (20μl). The molecular masses of polypeptides in each chromatographic fraction were 
further analysed using matrix-assisted laser desorption/ionisation, time-of-flight mass 
spectrometry (MALDI-TOF MS) on a linear time-of-flight Voyager DE mass spectrometer 
(Perseptive Biosystems, MA, USA) in positive detection mode using alpha-cyano-4-
hydroxycinnamic acid as the matrix. Internal mass calibration of the instrument with known 
standards established the accuracy of mass determination as ±0.1%.  
Peptide synthesis and purification 
Following unequivocal establishment of the primary structure of natural temporin-1Ee 
and temporin-1Re, replicates were synthesised by solid-phase Fmoc chemistry using a PS3 
automated peptide synthesiser (Protein Technologies, Tucson, AZ, USA). When the synthesis 
cycles were completed, the peptides were cleaved from the resins using 95/2.5/2.5 (v/v/v) 
TFA/TIPS/water for 6h, precipitated in ether over the next 24 h, washed exhaustively in six 
changes of ether and then allowed to completely dry over a further 24h. The peptides were 
then dissolved in a minimal quantity of 0.05/99.5, v/v, TFA/water, snap frozen in liquid 
 nitrogen and lyophilised. Degree of purity and authentication of structures of the synthetic 
peptides were determined using MALDI-TOF MS as previously described. 
Antimicrobial assays 
Antimicrobial activities of synthetic temporin-1Ee and temporin-1Re were assessed by 
determination of minimal inhibitory concentrations (MICs) using a standard Gram-positive 
bacterium S. aureus—NCTC 10788), a standard Gram-negative bacterium (Escherichia 
coli—NCTC 10418) and a standard pathogenic yeast (Candida albicans NCPF 1467). 
Temporin-1Ee and temporin-1Re were tested within the concentration range of 160–2.5μM 
and were initially dissolved as a stock solution of 200μM in sodium phosphate-buffered 
saline, pH 7.2, and subsequently diluted in Mueller–Hinton broth (MHB). Peptide 
concentrations in the range stated, were inoculated with microorganism cultures (105 colony 
forming units (CFU)/ml), and placed into 96-well microtiter cell culture plates. Plates were 
incubated for 18 h at 37°C in a humidified atmosphere. Following this, the growth of 
bacteria/yeast was determined by means of measuring optical density (OD) at λ=550nm by an 
ELISA plate reader (BioliseBioTek EL808). Minimal inhibitory concentrations (MICs) were 
defined as the lowest concentration at which no growth was detectable. 
 
 
 
 
 
 
 
 
 
 Results 
Molecular cloning of the A biosynthetic precursor 
Two different cDNAs, each encoding a novel peptide, named temporin-1Ee and 
temporin-1Re, respectively, were consistently and repeatedly cloned from the library during 
RACE-PCR experiments (Figure1).  Such experiments used R. esculenta skin mRNA as a 
template and specific oligonucleotides, designed to a conserved region (Signal peptide and 
3’-UTR) of previously cloned preprotemporincDNAs from other ranid species. The cDNAs 
amplified were separated on agarose gels then isolated with the cloning vector which was 
transformed into host cells. The white and drug resistant bacterial colonies were chosen by 
random and subjected to nucleotide sequence analysis. Alignment of temporin-1Ee and -1Re 
nucleotide sequences and open-reading frame amino acid sequences, using the AlignX 
programme of the Vector NTI Bioinformatics suite (Informax), revealed a very high degree 
of primary structural similarity of both nucleic acid and amino acid sequence between the 
temporin-1Ee and -1Re (Figure 2).An NCBI BLAST search found that the novel temporin-
1Ee showed at least 92% sequence identity with temporin-1Ec and peptide A1 and peptide 
B9 obtained from R. esculenta, previously (Table 2).  In the precursor sequence, the first 22 
amino acid residues encoded a putative signal peptide at the N-terminal followed by an acidic 
amino acid residue rich spacer peptide consisting of 21 amino acids for temporin-1Ee and 22 
amino acids for temproin-1Re with a pair of classical basic residue -Lys-Arg- (-K-R-) 
propeptide convertase cleavage sites at its C-terminus. A single copy of a mature temporin 
sequence was found at the C-terminus just upstream of a Gly residue that serves as an amide 
donor for the C-terminal residue of the temporin. The nucleotide sequence of the temporin-
1Ee and temporine-1Re precursors from the skin secretion of the European edible frog, 
Pelophylax kl.esculentus, have been deposited in the EMBL Nucleotide Sequence Database 
under the accession code KT437658 and  KT437659. 
 Identification and structural analysis of mature temporin-1Ee and temporin-1Re in skin 
secretion fractions and subsequent chemical synthesis 
The two novel temporins (temporin-1Ee: FLPVIAGVLSKLF-amide and temporin-1Re: 
FLPGLLAGLL-amide ), deduced from cloned skin cDNAs, with computed molecular mass 
of 1402.08Da and 1012.32Da, respectively, were identified in HPLC fraction numbers 164 
and 143, respectively (Figures 3 and 4).  Both temporins were successfully obtained by the 
solid-phase chemical synthesis. The reverse phase HPLC chromatogramsobtained from each 
synthesis following cleavage from the resin and deprotection, showed major peaks in each 
case representing approximately 95% of the synthetic mixture and these were subjected to 
MALDI–TOF mass analysis. In each case, molecular ions consistent with predicted 
molecular masses of respective novel temporinswere observed indicating successful 
syntheses and confirming a high degree of purity (>95%) of the expected products. 
Antimicrobial/hemolytic activity oftemporin-1Ee and temporin-1Re 
The abilities of temporin-1Ee and temporin-1Re peptides to inhibit the growth of the 
tested microorganisms employed are compared in Table 3. MICs obtained against S. aureus 
were 10 µM for temporin-1Ee and 60 µM for temporin-1Re. Moreover, temporin-1Ee 
displayed an inhibitory effect on the growth of the Gram-negative bacterium,E.coli, MIC was 
40 µM, whereas temporin-1Re exhibit no effect. Both temporins were ineffective in 
inhibiting the growth of the yeast, C. albicans, at concentrations up to and including 160µM.  
Moreover,temporin-1Ee was found to possess no haemolytic activity at the MIC (10μM) 
determined for S. aureus. This experiment was repeated five times. 
 
 
 
 
 Discussion 
The AMPs stored in the glands of frog skin display a complicated array of typical 
peptide physico-chemical attributes related to size, charge, hydrophobicity, degree of 
secondary structure formation and amphipathicity. Temporins have been intensely-studied 
due to their potent activity against Gram-positive bacteria, including clinical isolates of 
methicillin-resistant Staphylococcus aureus and vancomycin-resistantEntercoccusfaeciumand 
Enterococcus faecalis (9,12). However, due to their small size and low charge, the 
antimicrobial activity mechanisms of temporins are still unclear. The most recent research 
has provided some new insights to explain the mechanism of action of the temporins. Take 
temporin-L as an example. Temporin-L is a 13-mer peptide in which a tail-to-tail 
dimerisation can occur that then suits the barrel-stave model, binding to the vesicles surface, 
and undergoing a rapid local aggregation that causes a reorientation. Membrane insertion 
steps can only occur after this oligomerisation (12-14). We presume that temporin-1Ee, 
which has the same chain length as temporin-L and also possesses antimicrobial activity 
against both Gram-negative and Gram-positive bacteria, may act via a similar mechanism in 
which the carpet model could explain this temporin’s antimicrobial activity but the barrel-
stave model could explain the haemolytic effect (1-3, 15). 
Hence the variation in net charges (0 to +3), chain length (generally 10-14 residues), and 
amino acid sequences could influence the efficacy and selectivity of temporins against 
pathogens. Most members of the temporin family carry a low net charge of 0 or +1 at 
physiological pH and their chain lengths are restricted and small. Within the temporins, the 
higher the net positive charge (+2 or +3), the more potent they are in killing bacteria. 
Temporin-1Ee, with a net charge of +2, is more potent (MIC 10µM) than temporin-1Re (MIC 
60µM), with a net charge of +1, in killing the model Gram-positive bacterium, 
Staphylococcus aureus (NCTC 10788). In contrast, due to most of the natural 
 temporinshaving a weak charge and small size, they generally have little or no effects on 
Gram-negative bacteria, fungi and yeasts (16-20). However, one of the prototype temporins, 
temporin L (13 residues, net charge +3), was found to exhibit broad-spectrum activity against 
many microorganisms, including Gram-positive bacteria, Gram-negative bacteria and yeast, 
even cancer cells and human erythrocytes. Many additional temporins subsequently 
discovered exhibit broad-spectrum antimicrobial activity, examples being temporin-1Sa (11) 
and temporin-1DRa (21-22). Temporin-1Ee, with a net charge of +2, has efficacy and a high 
degree of activity against the model Gram-positive bacterium, S. aureus, with an MIC close 
to that of temporin-1Ec (MIC 8µM) (23). However temporin-1Ee, which has an amino acid 
sequence quite similar to that of temporin-1Ec with just one chemically-conservative 
substitution (Val8 instead of Leu8 – Table 2.), is able to inhibit the growth of the model 
Gram-negative bacterium, Escherichia coli.  Thus even conservative, single-site substitutions 
can dramatically change the spectrum of activity of a given temporin.  The temporins and 
their analogues are thus well accepted candidates for the design of new antimicrobial peptides 
for reasons such as above, where small changes in amino acid sequence can result in dramatic 
improvements in antimicrobial activity but retaining a weak haemolytic activity (24-27). 
These factors bode well for translating temporins into clinically useful anti-infective agents to 
combat antibiotic-resistant pathogens. 
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Legends to Figures 
Figure 1.Nucleotide sequences of cloned cDNAs encoding the biosynthetic precursors of temporin-
1Ee (A) and -1Re (B) and translated amino acid sequences of their open-reading frames. Putative 
signal peptides are double-underlined, mature peptides are single-underlined and the stop codons are 
indicated by asterisks. The G residue (italics) at the C-terminal of the mature peptide sequence serves 
as an amide donor after removal of the Lys residue (italics) with a carboxypeptidase. Residues G or 
GK (italics) at the end of the mature peptide sequence serve for C-terminal amidation. 
Figure 2.(A) Alignment of full-length nucleotide sequences of clones encoding the precursors of 
temporin-1Ee and temporin-1Re. DNA sequences were copied in FASTA format, which were then 
subjected to multiple sequence alignment by the CLUSTALW program. (B) Alignment of open-
reading frame amino acid sequences of preprotemporin-1Ee and preprotemporin-1Re. The conserved 
residues are shaded. Amino acid sequences were copied in FASTA format, which were then subjected 
to multiple sequence alignment by the CLUSTALW program. 
Figure 3.Reverse phase HPLC chromatogram of the skin secretion from Rana esculenta with arrows 
indicating elution positions/retention times of the two novel antimicrobial peptides, temporin-1Re and 
temporin-1Ee.  The Y-axis indicates absorbance units at λ=214nm. 
Figure 4. (A) MALDI–TOF mass spectrum showing major peptide molecular ion in reverse phase 
HPLC fraction 164 of Pelophylax kl. esculentus skin secretion corresponding in mass to 
temporin-1Ee (1402.08Da). (B) MALDI–TOF mass spectrum of peptide molecular ion in reverse 
phase HPLC fraction 143 of skin extract corresponding to temporin-1Re (1012.32Da). 
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